September, 2012
At the 4th European Paediatric Formulation Initiative held in Prague, Therakind presented the case study of Buccolam®, the first example of successful achievement of a centralised Paediatric Use Marketing Authorisation (PUMA).
At the 4th European Paediatric Formulation Initiative held in Prague, Therakind presented the case study of Buccolam®, the first example of successful achievement of a centralised Paediatric Use Marketing Authorisation (PUMA).